Tanin Intragumtornchai
Overview
Explore the profile of Tanin Intragumtornchai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tirachotikul T, Rattanathammethee T, Makruasi N, Chintabanyat A, Julamanee J, Khuhapinant A, et al.
Ann Hematol
. 2024 Aug;
103(12):5741-5748.
PMID: 39177795
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare subtype of T-cell lymphomas with a characteristic feature of subcutaneous nodules associated with hemophagocytic lymphohistiocytosis (HLH). Treatment options for SPTCL are mainly...
2.
Thanhakun R, Wudhikarn K, Bunworasate U, Rattanathammethee T, Norasetthada L, Kanya P, et al.
Ann Hematol
. 2023 Sep;
102(12):3533-3541.
PMID: 37718327
Several prognostic models have been introduced to predict outcomes of patients with diffuse large B-cell lymphoma (DLBCL). Endothelial activation and stress index (EASIX) is a surrogate of endothelial dysfunction which...
3.
Rattanathammethee T, Norasetthada L, Bunworasate U, Wudhikarn K, Julamanee J, Noiperm P, et al.
Ann Hematol
. 2023 May;
102(7):1887-1895.
PMID: 37202499
Relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) is a challenging condition to treat, and there is an unmet clinical need for effective therapies. Recently, polatuzumab vedotin (Pola), an anti-CD79b antibody-drug-conjugate...
4.
Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, et al.
Leuk Lymphoma
. 2020 Jun;
61(11):2614-2621.
PMID: 32573294
Event-free survival at 12 months (EFS12) is a surrogate endpoint for long-term outcomes in many histologic lymphoma subtypes. However, most reports have primarily investigated the implication of EFS12 in advanced-stage...
5.
Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, et al.
Hematol Oncol
. 2019 Nov;
37(5):578-585.
PMID: 31702065
Event free survival at 24 months (EFS24) has been described as a powerful predictor for outcome in several subtypes of B cell lymphoma. However, it was limitedly described in T...
6.
Bachy E, Seymour J, Feugier P, Offner F, Lopez-Guillermo A, Belada D, et al.
J Clin Oncol
. 2019 Jul;
37(31):2815-2824.
PMID: 31339826
Purpose: The PRIMA study (ClinicalTrials.gov identifier: NCT00140582) established that 2 years of rituximab maintenance after first-line immunochemotherapy significantly improved progression-free survival (PFS) in patients with follicular lymphoma compared with observation....
7.
Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, et al.
J Geriatr Oncol
. 2019 Apr;
11(1):62-68.
PMID: 30940492
Introduction: Peripheral T cell NHL (PTCL) and natural killer/T cell NHL (NKTCL) are relatively rare disorders. Data on clinical presentation, treatment and outcome are limited especially in older age groups....
8.
Leelarasamee A, Intragumtornchai T, Pannarunothai S, Laohavinij S, Patjanasoontorn B, Suntorntham S, et al.
J Med Assoc Thai
. 2018 Jun;
100(2):239-53.
PMID: 29916648
Background: Matching supply side of the Internal Medicine (IM) subspecialists to the demand for complex medical care at referral medical centers would lead to more efficient health system management and...
9.
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
Bachy E, Maurer M, Habermann T, Gelas-Dore B, Maucort-Boulch D, Estell J, et al.
Blood
. 2018 Apr;
132(1):49-58.
PMID: 29666118
In follicular lymphoma (FL), no prognostic index has been built based solely on a cohort of patients treated with initial immunochemotherapy. There is currently a need to define parsimonious clinical...
10.
Faknuam S, Assanasen T, Ruangvejvorachai P, Hanvivadhanakul P, Intragumtornchai T, Rojnuckarin P
Hematology
. 2017 Oct;
23(4):235-241.
PMID: 29032728
Objectives: Estrogen receptor beta (ERβ)-selective agonists inhibited B cell lymphoma growth in animal models. However, a recent study found that higher ERβ expression in tissue from diffuse large B cell...